# A Study of LY4064809 in Healthy Adult Chinese Participants

> **NCT07247357** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 10 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY4064809

## Key facts

- **NCT ID:** NCT07247357
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-10-24
- **Primary completion:** 2025-12-16
- **Final completion:** 2025-12-16
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2026-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07247357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07247357, "A Study of LY4064809 in Healthy Adult Chinese Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07247357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*